The discovery and development of novel pharmaceutical agents is characterized by high costs, lengthy timelines, and significant safety concerns. Traditional drug discovery involves pharmacologists manually screening drug molecules against protein targets, focusing on binding within protein cavities. However, this manual process is slow and inherently limited.
View Article and Find Full Text PDF